Astrana Health (NASDAQ:ASTH) Announces Earnings Results, Misses Expectations By $0.01 EPS

Astrana Health (NASDAQ:ASTH) announced its quarterly earnings data on Tuesday. The company reported $0.31 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.01), Briefing.com reports. The business had revenue of $404.36 million during the quarter, compared to the consensus estimate of $413.84 million. Astrana Health had a net margin of 4.49% and a return on equity of 11.52%. The firm’s revenue for the quarter was up 19.9% compared to the same quarter last year. During the same quarter last year, the company earned $0.42 EPS. Astrana Health updated its FY24 guidance to $1.28 to $1.52 EPS.

Astrana Health Stock Performance

Astrana Health stock traded down $0.77 during midday trading on Wednesday, reaching $37.16. 32,939 shares of the stock were exchanged, compared to its average volume of 152,609. The firm has a fifty day simple moving average of $40.36. The company has a current ratio of 2.11, a quick ratio of 2.11 and a debt-to-equity ratio of 0.42. Astrana Health has a 52 week low of $28.86 and a 52 week high of $45.71. The stock has a market cap of $2.08 billion, a price-to-earnings ratio of 26.77, a PEG ratio of 1.20 and a beta of 1.12.

Analyst Ratings Changes

Several research firms recently weighed in on ASTH. Stifel Nicolaus reduced their price target on shares of Astrana Health from $50.00 to $45.00 and set a “buy” rating for the company in a research report on Wednesday. Truist Financial raised their price target on shares of Astrana Health from $41.00 to $44.00 and gave the stock a “hold” rating in a research note on Friday, March 1st. Finally, Jefferies Financial Group began coverage on Astrana Health in a research note on Monday, February 26th. They issued a “buy” rating and a $50.00 price objective on the stock.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.